Publications by authors named "Fengsheng Tian"
Article Synopsis
- Monoclonal antibodies like recaticimab target PCSK9 to effectively lower LDL cholesterol levels, offering an alternative to more frequent treatments due to its long-acting nature.
- The study evaluated recaticimab's effectiveness and safety in patients with nonfamilial hypercholesterolemia and low-to-moderate atherosclerotic cardiovascular disease risk, comparing various dosing strategies.
- Results showed significant LDL-C reductions (up to 52.8%) compared to placebo, with safety profiles similar to that of placebo, suggesting recaticimab may provide a flexible treatment option for patients.
Aim: To evaluate the efficacy and safety of retagliptin in Chinese patients with type 2 diabetes (T2D) inadequately controlled with metformin.
Materials And Methods: This multicentre, phase 3 trial consisted of a 16-week, randomized, double-blind, placebo-controlled period, where patients with HbA1c levels between 7.5% and 11.
Article Synopsis
- The study aims to investigate how Rheum officeinale can protect blood vessels in rats with diabetes mellitus.
- After administering Rheum officeinale to diabetic rats for 8 weeks, researchers observed significant changes in blood markers and vessel responses.
- Findings indicated that Rheum officeinale reduced harmful endothelin-1 levels while increasing beneficial nitric oxide levels, and also inhibited the expression of certain proteins linked to inflammation in the blood vessels.
Objective: To observe clinical therapeutic effect of acupuncture on diabetic paralytic squint.
Methods: Seventy-two cases of diabetic paralytic squint were randomly divided into a medication group, an acupuncture group and an acupuncture and medication group. The medication group were treated with intramuscular injection of Methyl vitamin B12 250 microg, once daily; the acupuncture group were treated by acupuncture at different acupoints according to different paralytic muscles of eyes with adjuvant acupoints selected according to symptoms; the acupuncture and medication group were treated with the routine medicine and acupuncture.
Objective: To probe into a better therapy for diabetic neurogenic bladder.
Methods: The patients were randomly divided into a treatment group and a control group, 35 cases in each group. The control group were treated with intramuscular injection of Methycobal 250 microg, once every other day; the treatment group were treated with intramuscular injection of Methycobal 250 microg, once every other day, and acupuncture at Guanyuan (CV 4), Shenshu (BL 23), Ciliao (BL 32), Huiyang (BL 35), once every day.